Global Security Newswire
Daily News on Nuclear, Biological & Chemical Weapons, Terrorism and Related Issues
Trial Concludes for Experimental Bioagent Detector
An exhaustive trial has concluded for a technology touted as a potential component of the U.S. biological-strike warning infrastructure, the system's developer announced on Tuesday (see GSN, July 9).
Northrop Grumman's Next-Generation Automated Detection System is designed to independently capture atmospheric vapor and assess the gathered material for a number of potentially harmful organisms. The technology would provide multiple daily updates to medical authorities on its findings.
In the trial, the system conducted in excess of 20,000 assessments of atmospheric content in exposed areas and enclosed structures, according to the U.S. defense contractor.
"There are concerns that our nation won't be ready to respond should a biological attack occur," Dave Tilles, Homeland Security programs head for Northrop Grumman's Electronic Systems sector, said in released remarks. "Early warning provided by an automated detection system such as the [Next Generation Automated Detection System] will allow the nation's public health and public safety officials to proactively manage the response to a biological event to reduce exposure and treat the affected population to minimize casualties" (Northrop Grumman release, July 10).
The Homeland Security Department is expected later in 2012 to officially solicit technology proffers for the second stage of its Biowatch Generation 3 initiative, United Press International reported on Wednesday. The effort aims to field autonomous biological agent sensors in urban districts across the United States (United Press International, July 11).
This article provides an overview of the United States’ historical and current policies relating to nuclear, chemical, biological and missile proliferation.